Adverse Events Associated with Cardiac Catheterization in Children Supported with Ventricular Assist Devices - PubMed (original) (raw)

. 2022 Sep 1;68(9):1174-1181.

doi: 10.1097/MAT.0000000000001627. Epub 2021 Dec 28.

Affiliations

Adverse Events Associated with Cardiac Catheterization in Children Supported with Ventricular Assist Devices

Alyssa Power et al. ASAIO J. 2022.

Abstract

Children on ventricular assist device (VAD) support can present several unique challenges, including small patient size, univentricular or biventricular congenital heart disease (1V- or 2V-CHD) and need for biventricular VAD (BiVAD) support. While cardiac catheterization can provide valuable information, it is an invasive procedure with inherent risks. We sought to evaluate the safety of catheterization in pediatric patients on VAD support. We performed a retrospective review of patients on VAD support who underwent catheterization at Lucile Packard Children's Hospital between January 1, 2014 and September 1, 2019. Using definitions adapted from Pedimacs, adverse events (AEs) after catheterization were identified, including arrhythmia; major bleeding or acute kidney injury within 24 hours; respiratory failure persisting at 24 hours; and stroke, pericardial effusion, device malfunction, bacteremia or death within 7 days. AEs were categorized as related or unrelated to catheterization. Sixty procedures were performed on 39 patients. Underlying diagnoses were dilated cardiomyopathy (48%), 1V-CHD (35%), 2V-CHD (8%), and other (8%). Devices were implantable continuous flow (72%), paracorporeal pulsatile (18%) and paracorporeal continuous flow (10%). Catheterizations were performed on patients in the ICU (60%), on inotropic support (42%), with deteriorating clinical status (37%) and on BiVAD support (12%). There were 9 AEs possibly related to catheterization including 6 episodes of respiratory failure, 2 major bleeding events, and 1 procedural arrhythmia. AE occurrence was associated with ICU status ( P = 0.01), BiVAD support ( P = 0.04) and procedural indication to evaluate worsening clinical status ( P = 0.04). Despite high medical acuity, catheterization can be performed with an acceptable AE profile in children on VAD support.

Copyright © ASAIO 2021.

PubMed Disclaimer

Conflict of interest statement

Disclosure: There are no conflicts of interest to report

References

    1. Mansfield RT, Lin KY, Zaoutis T, et al.: The use of pediatric ventricular assist devices in children’s hospitals from 2000 to 2010: Morbidity, mortality, and hospital charges. Pediatr Crit Care Med 16: 522528, 2015.
    1. Morales DL, Almond CS, Jaquiss RD, et al.: Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant 30: 1–8, 2011.
    1. O’Connor MJ, Lorts A, Davies RR, et al.: Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis. J Heart Lung Transplant 39: 573–579, 2020.
    1. Morales DLS, Rossano JW, VanderPluym C, et al.; Pedimacs Investigators: Third annual pediatric interagency registry for mechanical circulatory support (pedimacs) report: preimplant characteristics and outcomes. Ann Thorac Surg 107: 993–1004, 2019.
    1. Peng DM, Rosenthal DN, Zafar F, Smyth L, VanderPluym CJ, Lorts A: Collaboration and new data in ACTION: a learning health care system to improve pediatric heart failure and ventricular assist device outcomes. Transl Pediatr 8: 349–355, 2019.

MeSH terms

LinkOut - more resources